Literature DB >> 10573682

Use of routine and breakthrough analgesia in home care.

B R Ferrell1, G Juarez, T Borneman.   

Abstract

PURPOSE/
OBJECTIVES: To describe current use of routine analgesics in home care and the treatment of breakthrough pain.
DESIGN: Descriptive, companion study.
SETTING: Homecare agencies in southern California. SAMPLE: Convenience sample of 369 patients with cancer participating in a pain-education study.
METHODS: Data regarding breakthrough pain were derived from the homecare medical records and patient interviews. MAIN RESEARCH VARIABLES: Analgesic medications prescribed and used for treatment of routine and breakthrough cancer pain.
FINDINGS: Results demonstrate discrepancy between recommended pain management in clinical practice guidelines and the actual practice of pain management at home. Deficiencies were found in medications prescribed as well as in actual use by patients.
CONCLUSIONS: Optimum relief of cancer pain is contingent on adequate treatment of routine and breakthrough pain, including greater use of recommended analgesics in adequate doses and clinical care consistent with clinical practice guidelines. IMPLICATIONS FOR NURSING PRACTICE: Breakthrough pain is a common problem affecting the quality of life of patients with cancer. Improved management of breakthrough pain is contingent on accurate pain assessment, optimum use of analgesics, and patient education. Nurses should address the important topic of breakthrough pain as new analgesic drugs and methods of delivery become available.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10573682

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  3 in total

1.  An examination of adherence to pain medication plans in older cancer patients in hospice care.

Authors:  Sara Sanders; Keela A Herr; Perry G Fine; Catherine Fiala; Xiongwen Tang; Chris Forcucci
Journal:  J Pain Symptom Manage       Date:  2012-07-26       Impact factor: 3.612

2.  Clinical management of pain in advanced lung cancer.

Authors:  Claribel P L Simmons; Nicholas Macleod; Barry J A Laird
Journal:  Clin Med Insights Oncol       Date:  2012-10-08

3.  Budget impact analysis of the fentanyl buccal tablet for treatment of breakthrough cancer pain.

Authors:  Josep Darbà; Lisette Kaskens; Rainel Sánchez-de la Rosa
Journal:  Clinicoecon Outcomes Res       Date:  2013-12-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.